US Stock MarketDetailed Quotes

VIRX Viracta Therapeutics

Watchlist
  • 0.200
  • +0.006+2.88%
Close Nov 4 16:00 ET
  • 0.196
  • -0.005-2.25%
Post 16:56 ET
7.88MMarket Cap-172P/E (TTM)

Viracta Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Viracta Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 0.000--
--2024/Q3-- / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 0.000--
--2024/Q3-- / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--

Unlock Free Earnings Estimates

Viracta Therapeutics Earnings Reports

  • Viracta Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 15 04:12

  • Viracta Therapeutics | 10-Q: Q1 2024 Earnings Report

    May 10 05:10

  • Viracta Therapeutics | 10-K: FY2023 Annual Report

    Mar 8 05:27

  • Viracta Therapeutics | 10-Q: Q3 2023 Earnings Report

    Nov 10, 2023 05:32

    • Read more

    Analysis

    Analyst Rating

    Updated: Oct 31, 2024

    Buy

    • Buy

      50.00%

    • Hold

      50.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data